Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Ranking Vaccines: A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System

Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase II; Board on Population Health and Public Health Practice; Board on Global Health; Institute of Medicine
Guruprasad Madhavan, Kinpritma Sangha, Charles Phelps, Dennis Fryback, Rino Rappuoli, Rose Marie Martinez, Lonnie King
, editors.
Washington (DC): National Academies Press (US); 2013 Oct 17.
Free Books & Documents
Review

Ranking Vaccines: A Prioritization Software Tool: Phase II: Prototype of a Decision-Support System

Committee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase II et al.
Free Books & Documents

Excerpt

SMART Vaccines--Strategic Multi-Attribute Ranking Tool for Vaccines--is a prioritization software tool developed by the Institute of Medicine that utilizes decision science and modeling to help inform choices among candidates for new vaccine development. A blueprint for this computer-based guide was presented in the 2012 report Ranking Vaccines: A Prioritization Framework: Phase I.

Ranking Vaccines: A Prioritization Software Tool, Phase II extends the proof-of-concept presented in the Phase I report, which was based on multi-attribute utility theory. This report refines a beta version of the model developed in the Phase I report and presents its next iteration, SMART Vaccines 1.0.

Ranking Vaccines: Phase II discusses the methods underlying the development, validation, and evaluation of SMART Vaccines 1.0. It also discusses how SMART Vaccines should--and, just as importantly, should not--be used. The report also offers ideas for future enhancements for SMART Vaccines as well as for ideas for expanded uses and considerations and possibilities for the future.

PubMed Disclaimer

Grants and funding

This study was supported by Contract No. HHSP23337024T, TO #45 between the National Academy of Sciences and the National Vaccine Program Office of the Department of Health and Human Services. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the editors and do not necessarily reflect the view of the organizations or agencies that provided support for this project.

LinkOut - more resources